A retrospective clinical study of the treatment of slow-channel congenital myasthenic syndrome

被引：32

作者：

Chaouch, A. ^{[1
]}

Mueller, J. S. ^{[2
]}

Guergueltcheva, V. ^{[2
,3
]}

Dusl, M. ^{[2
]}

Schara, U. ^{[4
]}

Rakocevic-Stojanovic, V. ^{[5
]}

Lindberg, C. ^{[6
]}

Scola, R. H. ^{[7
]}

Werneck, L. C. ^{[7
]}

Colomer, J. ^{[8
]}

Nascimento, A. ^{[8
]}

Vilchez, J. J. ^{[9
,10
,11
]}

Muelas, N. ^{[9
,10
,11
]}

Argov, Z. ^{[12
]}

Abicht, A. ^{[2
]}

Lochmueller, H. ^{[1
]}

机构：

[1] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England

[2] Univ Munich, Dept Neurol, Friedrich Baur Inst, D-8000 Munich, Germany

[3] Univ Hosp Alexandrovska, Clin Neurol, Sofia, Bulgaria

[4] Univ Essen Gesamthsch, Essen, Germany

[5] Univ Belgrade, Sch Med, Inst Neurol, Belgrade, Serbia

[6] Sahlgrens Univ Hosp, Dept Pathol, Goteborg Neuromuscular Ctr, Gothenburg, Sweden

[7] Univ Fed Parana, Hosp Clin, Neuromuscular Neurol Div, BR-80060000 Curitiba, Parana, Brazil

[8] Hosp St Joan de Deu, Unitat Patol Neuromuscular, Barcelona, Spain

[9] Univ Hosp, Serv Neurol, Valencia, Spain

[10] Politecn La Fe, Valencia, Spain

[11] CIBER Enfermedades Neurodegenerat CIBERNED, Madrid, Spain

[12] Hadassah Univ Hosp, Dept Neurol, IL-91120 Jerusalem, Israel

来源：

NEUROMUSCULAR DISORDERS | 2012年 / 22卷

基金：

英国医学研究理事会;

关键词：

D O I：

10.1016/j.nmd.2011.12.004

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S16 / S17

页数：2

共 50 条

[41] A Missense Mutation in Epsilon-subunit of Acetylcholine Receptor Causing Autosomal Dominant Slow-channel Congenital Myasthenic Syndrome in a Chinese Family
Jia-Ze Tan
Yuan Man
Fei Xiao
中华医学杂志英文版, 2016, 129 (21) : 2596 - 2602
[42] Selective inhibition of caspases in skeletal muscle reverses the apoptotic synaptic degeneration in slow-channel myasthenic syndrome
Zhu, Haipeng
Pytel, Peter
Gomez, Christopher M.
HUMAN MOLECULAR GENETICS, 2014, 23 (01) : 69 - 77
[43] Slow channel congenital myasthenic syndrome responsive to a combination of fluoxetine and salbutamol
Finlayson, Sarah
Spillane, Jennifer
Kullmann, Dimitri M.
Howard, Robin
Webster, Richard
Palace, Jacqueline
Beeson, David
MUSCLE & NERVE, 2013, 47 (02) : 279 - 282
[44] Characterization of novel slow-channel congenital myasthenic syndrome (SCCMS) mutation in transmembrane domain-2 (TMD2) of the AChR δ subunit
Shen, XM
Milone, M
Banwell, B
Engel, AG
NEUROLOGY, 2006, 66 (05) : A58 - A58
[45] Slow-channel congenital myasthenic syndrome (SCCMS) caused by a novel epsilon subunit mutation in the second AChR transmembrane domain (TMD2)
Shen, XM
Ohno, K
Adams, C
Engel, AG
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 199 : S96 - S96
[46] Salbutamol as effective treatment in slow-channel syndrome-first report
Santovito, Luca Spiro
Brugnoni, Raffaella
Banfi, Paolo
Maggi, Lorenzo
NEUROLOGICAL SCIENCES, 2021, 42 (04) : 1611 - 1612
[47] Salbutamol as effective treatment in slow-channel syndrome- first report
Luca Spiro Santovito
Raffaella Brugnoni
Paolo Banfi
Lorenzo Maggi
Neurological Sciences, 2021, 42 : 1611 - 1612
[48] Slow-channel congenital myasthenic syndrome cause by delay closing and opening and agonist block due to a mutation in the M2 domain of the δ subunit
Navedo, MF
Nieves, M
Rojas, L
Gomez, C
Lasalde-Dominicci, J
BIOPHYSICAL JOURNAL, 2002, 82 (01) : 214A - 214A
[49] Transgenic mouse model of the slow-channel syndrome
Gomez, CM
Bhattacharyya, BB
Charnet, P
Day, JW
Labarca, C
Wollmann, RL
Lambert, EH
MUSCLE & NERVE, 1996, 19 (01) : 79 - 87
[50] Quinine sulfate as a therapeutic option in a patient with Slow channel congenital myasthenic syndrome
Peyer, Anne-Kathrin
Abicht, Angela
Heinimann, Karl
Sinnreich, Michael
Fischer, Dirk
NEUROMUSCULAR DISORDERS, 2013, 23 (07) : 571 - 574

← 1 2 3 4 5 →